Epidemiological Characteristics of the Human Papilloma Virus in Women in Uzbekistan

Authors

  • Rakhmanova Jamila Tashkent Institute of Postgraduate Medical Education, Uzbekistan Author

DOI:

https://doi.org/10.61841/5dbv3z98

Keywords:

human papillomavirus, phylogenetic groups, cervical cancer, screening, vaccination

Abstract

This article examines the epidemiological characteristics of the human papillomavirus in Uzbekistan. The report presents data on the prevalence of phylogenetic groups identified as a result of the research carried out, as well as the age-specific features of the spread of the human papillomavirus and their combination. Recommendations on preventing the spread of human papillomavirus by introducing vaccination and conducting screening tests for women to prevent cervical cancer. 

Downloads

Download data is not yet available.

References

1. Mayansky A.N. Human papilloma virus is an oncogenic virus. Nizhny Novgorod State Medical Academy. Lecture. 2010. 48-55.

2. Andosova L.D., Kontorschikova K.N., etc. Detection of human papilloma virus with high carcinogenic risk in

women of reproductive age. Gynecology. Medical Almanac .2010 (4). 155-157.Gissmann L, Boshart M, Dürst

M, Ikenberg H, Wagner D, zurHausen H. Presence of human papillomavirus in genital tumors. J Invest Dermatol. 1984 Jul; 83(1 Suppl): 26s–8s.

3. Gissmann L. Human papillomaviruses and genital cancer [R]. Semin Cancer Biol. 1992 Oct; 3(5): 253–61.

4. Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol. 2015; 125(2):330–337. doi:10.1097/AOG.0000000000000669.

5. Laimins LA (1993) The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis 2(2):74– 86 6 Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, et al.; NCI HPV Workshop. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses. 2018 Feb; 10(2):E80.

6. Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, et al.; NCI HPV Workshop. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses. 2018 Feb; 10(2):E80.

7. Poljak M, Kocjan BJ, Oštrbenk A, Seme K. Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol. 2016 Mar; 76 Suppl 1:S3–13.

8. zurHausen H H, de Villiers EM (1994) Human papillomaviruses. Annu Rev Microbiol 48:427–447.

9. zurHausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009 Feb; 384(2): 260–5.

10. Saslow D, Solomon D, Lawson HW, et al; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137(4):516–542.

doi:10.1309/AJCPTGD94EVRSJCG.

11. Syrjänen KJ, Syrjänen SM. Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix. Ann Clin Res. 1985; 17(2): 45–56.

Downloads

Published

30.04.2020

Issue

Vol. 24 No. 2 (2020): 24 (2) 2020

Section

Articles

License

Copyright (c) 2020 AUTHOR

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Jamila, R. (2020). Epidemiological Characteristics of the Human Papilloma Virus in Women in Uzbekistan. International Journal of Psychosocial Rehabilitation, 24(2), 427-433. https://doi.org/10.61841/5dbv3z98